1
|
Pomazal R, Malecki K, Stanton N, Shelton B, Lange M, Irving R, Meiman J, Remucal CK, Cochran A, Schultz AA. Determinants of per- and polyfluoroalkyl substances (PFAS) exposure among Wisconsin residents. ENVIRONMENTAL RESEARCH 2024; 254:119131. [PMID: 38759771 DOI: 10.1016/j.envres.2024.119131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Revised: 05/07/2024] [Accepted: 05/09/2024] [Indexed: 05/19/2024]
Abstract
BACKGROUND Per- and polyfluoroalkyl substances (PFAS) include thousands of manufactured compounds with growing public health concerns due to their potential for widespread human exposure and adverse health outcomes. While PFAS contamination remains a significant concern, especially from ingestion of contaminated food and water, determinants of the variability in PFAS exposure among regional and statewide populations in the United States remains unclear. OBJECTIVES The objective of this study was to leverage The Survey of the Health of Wisconsin (SHOW), the only statewide representative cohort in the US, to assess and characterize the variability of PFAS exposure in a general population. METHODS This study sample included a sub-sample of 605 adult participants from the 2014-2016 tri-annual statewide representative sample. Geometric means for PFOS, PFOA, PFNA, PFHxS, PFPeS, PFHpA, and a summed measure of 38 analyzed serum PFAS were presented by demographic, diet, behavioral, and residential characteristics. Multivariate linear regression was used to determine significant predictors of serum PFAS after adjustment. RESULTS Overall, higher serum concentrations of long-chain PFAS were observed compared with short-chain PFAS. Older adults, males, and non-Hispanic White individuals had higher serum PFAS compared to younger adults, females, and non-White individuals. Eating caught fish in the past year was associated with elevated levels of several PFAS. DISCUSSION This is among the first studies to characterize serum PFAS among a representative statewide sample in Wisconsin. Both short- and long-chain serum PFAS were detectable for six prominent PFAS. Age and consumption of great lakes fish were the most significant predictors of serum PFAS. State-level PFAS biomonitoring is important for identifying high risk populations and informing state public health standards and interventions, especially among those not living near known contamination sites.
Collapse
Affiliation(s)
- Rachel Pomazal
- University of Wisconsin-Madison, Department of Population Health Sciences, Madison, WI, USA
| | - Kristen Malecki
- Division of Environmental and Occupational Health Sciences, University of Illinois Chicago School of Public Health, Chicago, IL, USA
| | - Noel Stanton
- Wisconsin State Lab of Hygiene, Madison, WI, USA
| | | | - Meshel Lange
- Wisconsin State Lab of Hygiene, Madison, WI, USA
| | - Roy Irving
- Wisconsin Department of Health Services Madison, WI, USA
| | | | - Christina K Remucal
- University of Wisconsin-Madison, Department of Civil and Environmental Engineering, Madison, WI, USA
| | - Amy Cochran
- University of Wisconsin-Madison, Department of Population Health Sciences, Madison, WI, USA
| | - Amy A Schultz
- University of Wisconsin-Madison, Department of Population Health Sciences, Madison, WI, USA.
| |
Collapse
|
2
|
Stingone JA, Geller AM, Hood DB, Makris KC, Mouton CP, States JC, Sumner SJ, Wu KL, Rajasekar AK. Community-level exposomics: a population-centered approach to address public health concerns. EXPOSOME 2023; 3:osad009. [PMID: 38550543 PMCID: PMC10976977 DOI: 10.1093/exposome/osad009] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2024]
Abstract
Environmental factors affecting health and vulnerability far outweigh genetics in accounting for disparities in health status and longevity in US communities. The concept of the exposome, the totality of exposure from conception onwards, provides a paradigm for researchers to investigate the complex role of the environment on the health of individuals. We propose a complementary framework, community-level exposomics, for population-level exposome assessment. The goal is to bring the exposome paradigm to research and practice on the health of populations, defined by various axes including geographic, social, and occupational. This framework includes the integration of community-level measures of the built, natural and social environments, environmental pollution-derived from conventional and community science approaches, internal markers of exposure that can be measured at the population-level and early responses associated with health status that can be tracked using population-based monitoring. Primary challenges to the implementation of the proposed framework include needed advancements in population-level measurement, lack of existing models with the capability to produce interpretable and actionable evidence and the ethical considerations of labeling geographically-bound populations by exposomic profiles. To address these challenges, we propose a set of recommendations that begin with greater engagement with and empowerment of affected communities and targeted investment in community-based solutions. Applications to urban settings and disaster epidemiology are discussed as examples for implementation.
Collapse
Affiliation(s)
- Jeanette A. Stingone
- Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA
| | - Andrew M. Geller
- Office of Research and Development, Environmental Protection Agency, RTP, NC, USA
| | - Darryl B. Hood
- Division of Environmental Health Sciences, The Ohio State University, Columbus, OH, USA
| | - Konstantinos C. Makris
- Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol, Cyprus
| | - Charles P. Mouton
- Department of Family Medicine, University of Texas Medical Branch Galveston, TX, USA
| | - J. Christopher States
- Center for Integrative Environmental Health Sciences, Department of Pharmacology and Toxicology University of Louisville School of Medicine, Louisville, KY, USA
| | - Susan J. Sumner
- Department of Nutrition, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA
| | - K. Lily Wu
- California Environmental Protection Agency—Office of Environmental Health Hazard Assessment, Sacramento, CA, USA
| | - Arcot K Rajasekar
- School of Information and Library Science, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA
| | | |
Collapse
|
3
|
Schultz AA, Stanton N, Shelton B, Pomazal R, Lange MA, Irving R, Meiman J, Malecki KC. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES). JOURNAL OF EXPOSURE SCIENCE & ENVIRONMENTAL EPIDEMIOLOGY 2023; 33:766-777. [PMID: 37580384 PMCID: PMC10804284 DOI: 10.1038/s41370-023-00593-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/09/2023] [Revised: 07/27/2023] [Accepted: 08/01/2023] [Indexed: 08/16/2023]
Abstract
BACKGROUND Per- and polyfluoroalkyl substances (PFAS) are a growing class of manufactured chemical compounds found in a variety of consumer products. PFAS are ubiquitous in the environment and were found in many humans sampled in the United States (U.S.). Yet, significant gaps in understanding statewide levels of exposure to PFAS remain. OBJECTIVE The goals of this study are to establish a baseline of exposure at the state level by measuring PFAS serum levels among a representative sample of Wisconsin residents and compare to United States National Health and Nutrition Examination Survey (NHANES). METHODS The study sample included 605 adults (18+ years of age) selected from the 2014-2016 sample of the Survey of the Health of Wisconsin (SHOW). Thirty-eight PFAS serum concentrations were measured using high-pressure liquid chromatography coupled with tandem mass spectrometric detection (HPLC-MS/MS) and geometric means were presented. Weighted geometric mean serum values of eight PFAS analytes from SHOW were compared to U.S. national levels from the NHANES 2015-2016 sample (PFOS, PFOA, PFNA, PFHxS, PFHpS, PFDA, PFUnDA), and the 2017-2018 sample for Me-PFOSA, PFHPS using the Wilcoxon rank-sum test. RESULTS PFOS, PFHxS, PFHpS, PFDA, PFNA, and PFOA were detected in over 96% of SHOW participants. In general, SHOW participants had lower serum levels across all PFAS when compared to NHANES. Serum levels increased with age and were higher among males and whites. Similar trends were seen in NHANES, except non-whites had higher PFAS levels at higher percentiles in NHANES. IMPACT STATEMENT The present study conducts biomonitoring of 38 PFAS among representative sample of residents in the state of Wisconsin. Results suggest that while the majority of Wisconsin residents tested have detectable levels of PFAS in their blood serum, they may have a lower body burden of some PFAS compared to a nationally representative sample. Older adults, males, and whites may have a higher body burden of PFAS relative to other groups, both in Wisconsin and the wider United States.
Collapse
Affiliation(s)
- Amy A Schultz
- Survey of the Health of Wisconsin (SHOW), University of Wisconsin Madison, Madison, WI, USA.
| | - Noel Stanton
- Wisconsin State Lab of Hygiene (WSLH), Madison, WI, USA
| | | | - Rachel Pomazal
- Survey of the Health of Wisconsin (SHOW), University of Wisconsin Madison, Madison, WI, USA
| | | | - Roy Irving
- Wisconsin Department of Health Services, Madison, WI, USA
| | | | - Kristen C Malecki
- Survey of the Health of Wisconsin (SHOW), University of Wisconsin Madison, Madison, WI, USA
- University of Illinois at Chicago School of Public Health, Chicago, IL, USA
| |
Collapse
|
4
|
Schultz A, Stanton N, Pomazal R, Lange M, Irving R, Meiman J, Shelton B, Malecki KCM. Biomonitoring of perfluoroalkyl and polyfluoroalkyl substances (PFAS) from the Survey of the Health of Wisconsin (SHOW) 2014-2016 and comparison with the National Health and Nutrition Examination Survey (NHANES). MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES 2023:2023.02.14.23285850. [PMID: 36865127 PMCID: PMC9980248 DOI: 10.1101/2023.02.14.23285850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
Background Per- and polyfluoroalkyl substances (PFAS) are a growing class of manufactured chemical compounds found in a variety of consumer products. PFAS have become ubiquitous in the environment and were found in many humans sampled in the United States (U.S.). Yet, significant gaps in understanding statewide level exposures to PFAS remain. Objective The goals of this study are to establish a baseline of exposure at the state level by measuring PFAS serum levels among a representative sample of Wisconsin residents and compare to United States National Health and Nutrition Examination Survey (NHANES). Methods The study sample included 605 adults (18+ years of age) selected from the 2014-2016 sample of the Survey of the Health of Wisconsin (SHOW). Thirty-eight PFAS serum concentrations were measured using high-pressure liquid chromatography coupled with tandem mass spectrometric detection (HPLC-MS/MS) and geometric means presented. Weighted geometric mean serum values of eight PFAS analytes from SHOW were compared to U.S. national levels from the NHANES 2015-2016 sample (PFOS, PFOA, PFNA, PFHxS, PFHpS, PFDA, PFUnDA), and the 2017-2018 sample for Me-PFOSA, PFHPS using the Wilcoxon rank-sum test. Results Over 96% of SHOW participants had positive results for PFOS, PFHxS, PFHpS, PFDA, PFNA, and PFOA. In general, SHOW participants had lower serum levels across all PFAS when compared to NHANES. Serum levels increased with age and were higher among males and whites. These trends were seen in NHANES, except non-whites had higher PFAS levels at higher percentiles. Significance Wisconsin residents may have a lower overall body burden of some PFAS compounds compared to those seen by a nationally representative sample. Additional testing and characterization may be needed in Wisconsin, particularly among non-whites and low socioeconomic status, for which the SHOW sample had less representation compared to NHANES. Impact Statement The present study conducts biomonitoring of 38 PFAS in the state of Wisconsin and suggests that while most residents of Wisconsin have detectable levels of PFAS in their blood serum, they may have a lower body burden of some PFAS compared to a nationally representative sample. Older adults, males, and whites may have a higher body burden of PFAS relative to other groups both in Wisconsin and the wider United States.
Collapse
Affiliation(s)
- Amy Schultz
- Survey of the Health of Wisconsin (SHOW), University of Wisconsin Madison
| | | | - Rachel Pomazal
- Survey of the Health of Wisconsin (SHOW), University of Wisconsin Madison
| | | | | | | | | | - Kristen CM Malecki
- Survey of the Health of Wisconsin (SHOW), University of Wisconsin Madison
- University of Illinois at Chicago School of Public Health
| |
Collapse
|
5
|
MacDonald AM, Gabos S, Braakman S, Cheperdak L, Lee B, Hrudey SE, Le XC, Li XF, Mandal R, Martin JW, Schopflocher D, Lyon ME, Cheung PY, Ackah F, Graydon JA, Reichert M, Lyon AW, Jarrell J, Benadé G, Charlton C, Huang D, Bennett MJ, Kinniburgh DW. Maternal and child biomonitoring strategies and levels of exposure in western Canada during the past seventeen years: The Alberta Biomonitoring Program: 2005-2021. Int J Hyg Environ Health 2022; 244:113990. [PMID: 35714548 DOI: 10.1016/j.ijheh.2022.113990] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2022] [Revised: 05/13/2022] [Accepted: 05/31/2022] [Indexed: 10/18/2022]
Abstract
The Alberta Biomonitoring Program (ABP) was created in 2005 with the initial goal of establishing baseline levels of exposure to environmental chemicals in specific populations in the province of Alberta, Canada, and was later expanded to include multiple phases. The first two phases focused on evaluating exposure in pregnant women (Phase One, 2005) and children (Phase Two, 2004-2006) by analyzing residual serum specimens. Phase Three (2013-2016) employed active recruitment techniques to evaluate environmental exposures using a revised list of chemicals in paired serum pools from pregnant women and umbilical cord blood. These three phases of the program monitored a total of 226 chemicals in 285 pooled serum samples representing 31,529 individuals. Phase Four (2017-2020) of the ABP has taken a more targeted approach, focusing on the impact of the federal legalization of cannabis on the exposure of pregnant women in Alberta to cannabis, as well as tobacco and alcohol using residual prenatal screening serum specimens. Chemicals monitored in the first three phases include herbicides, neutral pesticides, metals, metalloids, and micronutrients, methylmercury, organochlorine pesticides, organophosphate pesticides, parabens, phthalate metabolites, perfluoroalkyl substances (PFAS), phenols, phytoestrogens, polybrominated compounds, polychlorinated biphenyls (PCBs), dioxins and furans, polycyclic aromatic hydrocarbons (PAHs), and tobacco biomarkers. Phase Four monitored six biomarkers of tobacco, alcohol, and cannabis. All serum samples were pooled. Mean concentrations and 95% confidence intervals (CIs) were calculated for the chemicals detected in ≥25% of the sample pools. cross the first three phases, the data from the ABP has provided baseline exposure levels for the chemicals in pregnant women, children, and newborns across the province. Comparison within and among the phases has highlighted differences in exposure levels with age, geography, seasonality, sample type, and time. The strategies employed throughout the program phases have been demonstrated to provide effective models for population biomonitoring.
Collapse
Affiliation(s)
- Amy M MacDonald
- Alberta Centre for Toxicology, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
| | - Stephan Gabos
- Alberta Centre for Toxicology, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | | | | | - Bonita Lee
- Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - Steve E Hrudey
- Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - X Chris Le
- Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - Xing-Fang Li
- Division of Analytical and Environmental Toxicology, Department of Laboratory Medicine and Pathology, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - Rupasri Mandal
- The Metabolomics Innovation Centre, Faculty of Science, University of Alberta, Edmonton, Alberta, Canada
| | - Jonathan W Martin
- Science for Life Laboratory, Department of Environmental Sciences, Stockholm University, Sweden
| | - Don Schopflocher
- Faculty of Nursing, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - Martha E Lyon
- Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
| | - Po-Yin Cheung
- Division of Neonatal-Perinatal Care (NICU), Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
| | - Fred Ackah
- Alberta Government, Strategic Data & Analytic Branch, Edmonton, Alberta, Canada
| | | | - Megan Reichert
- Alberta Health, Health Protection Branch, Edmonton, Alberta, Canada
| | - Andrew W Lyon
- Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
| | - John Jarrell
- Department of Obstetrics & Gynaecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Gerhard Benadé
- Emergency, Public Health & Preventive Medicine, Alberta Health Services, Edmonton, Alberta, Canada
| | - Carmen Charlton
- Alberta Precision Laboratory - Public Health Laboratory, University of Alberta Hospitals, Edmonton, Alberta, Canada
| | - Dorothy Huang
- Alberta Centre for Toxicology, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - Melissa J Bennett
- Alberta Centre for Toxicology, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| | - David W Kinniburgh
- Alberta Centre for Toxicology, Department of Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
| |
Collapse
|
6
|
Poutasse CM, Poston WSC, Jahnke SA, Haddock CK, Tidwell LG, Hoffman PD, Anderson KA. Discovery of firefighter chemical exposures using military-style silicone dog tags. ENVIRONMENT INTERNATIONAL 2020; 142:105818. [PMID: 32521346 PMCID: PMC9985454 DOI: 10.1016/j.envint.2020.105818] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 05/13/2020] [Accepted: 05/14/2020] [Indexed: 05/07/2023]
Abstract
Occupational chemical hazards in the fire service are hypothesized to play a role in increased cancer risk, and reliable sampling technologies are necessary for conducting firefighter chemical exposure assessments. This study presents the military-style dog tag as a new configuration of silicone passive sampling device to sample individual firefighters' exposures at one high and one low fire call volume department in the Kansas City, Missouri metropolitan area. The recruited firefighters (n = 56) wore separate dog tags to assess on- and off-duty exposures (ndogtags = 110), for a total of 30 24 h shifts. Using a 63 PAH method (GC-MS/MS), the tags detected 45 unique PAHs, of which 18 have not been previously reported as firefighting exposures. PAH concentrations were higher for on- compared to off-duty tags (0.25 < Cohen's d ≤ 0.80) and for the high compared to the low fire call volume department (0.25 ≤ d < 0.70). Using a 1530 analyte screening method (GC-MS), di-n-butyl phthalate, diisobutyl phthalate, guaiacol, and DEET were commonly detected analytes. The number of fire attacks a firefighter participated in was more strongly correlated with PAH concentrations than firefighter rank or years in the fire service. This suggested that quantitative data should be employed for firefighter exposure assessments, rather than surrogate measures. Because several detected analytes are listed as possible carcinogens, future firefighter exposure studies should consider evaluating complex mixtures to assess individual health risks.
Collapse
Affiliation(s)
- Carolyn M Poutasse
- Department of Toxicology, Oregon State University, Corvallis, OR 97331, USA
| | - Walker S C Poston
- Center for Fire, Rescue, and EMS Health Research, NDRI-USA, Leawood, KS 66224, USA
| | - Sara A Jahnke
- Center for Fire, Rescue, and EMS Health Research, NDRI-USA, Leawood, KS 66224, USA
| | | | - Lane G Tidwell
- Department of Toxicology, Oregon State University, Corvallis, OR 97331, USA
| | - Peter D Hoffman
- Department of Toxicology, Oregon State University, Corvallis, OR 97331, USA
| | - Kim A Anderson
- Department of Toxicology, Oregon State University, Corvallis, OR 97331, USA.
| |
Collapse
|
7
|
Sabbioni G, Berset JD, Day BW. Is It Realistic to Propose Determination of a Lifetime Internal Exposome? Chem Res Toxicol 2020; 33:2010-2021. [PMID: 32672951 DOI: 10.1021/acs.chemrestox.0c00092] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Biomonitoring of xenobiotics has been performed for many years in occupational and environmental medicine. It has revealed hidden exposures and the exposure of workers could be reduced. Although most of the toxic effects of chemicals on humans were discovered in workers, the scientific community has more recently focused on environmental samples. In several countries, urinary and blood samples have been collected and analyzed for xenobiotics. Health, biochemical, and clinical parameters were measured in the biomonitoring program of the Unites States. The data were collected and evaluated as group values, comparing races, ages, and gender. The term exposome was created in order to relate chemical exposure to health effects together with the terms genome, proteome, and transcriptome. Internal exposures were mostly established with snapshot measurements, which can lead to an obvious misclassification of the individual exposures. Albumin and hemoglobin adducts of xenobiotics reflect the exposure of a larger time frame, up to 120 days. It is likely that only a small fraction of xenobiotics form such adducts. In addition, adduct analyses are more work intensive than the measurement of xenobiotics and metabolites in urine and/or blood. New technology, such as high-resolution mass spectrometry, will enable the discovery of new compounds that have been overlooked in the past, since over 300,000 chemicals are commercially available and most likely also present in the environment. Yet, quantification will be challenging, as it was for the older methods. At this stage, determination of a lifetime internal exposome is very unrealistic. Instead of an experimental approach with a large number of people, which is economically and scientifically not feasible, in silico methods should be developed further to predict exposure, toxicity, and potential health effects of mixtures. The computer models will help to focus internal exposure investigations on smaller groups of people and smaller number of chemicals.
Collapse
Affiliation(s)
- Gabriele Sabbioni
- Institute of Environmental and Occupational Toxicology, CH-6780 Airolo, Switzerland.,Walther-Straub-Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, D-80336 München, Germany
| | - Jean-Daniel Berset
- Institute of Environmental and Occupational Toxicology, CH-6780 Airolo, Switzerland
| | - Billy W Day
- Medantox LLC, Pittsburgh, Pennsylvania 15241, United States.,ReNeuroGen LLC, Elm Grove, Wisconsin 53122, United States
| |
Collapse
|
8
|
Valcke M, Karthikeyan S, Walker M, Gagné M, Copes R, St-Amand A. Regional variations in human chemical exposures in Canada: A case study using biomonitoring data from the Canadian Health Measures Survey for the provinces of Quebec and Ontario. Int J Hyg Environ Health 2020; 225:113451. [PMID: 31972364 DOI: 10.1016/j.ijheh.2020.113451] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Revised: 12/03/2019] [Accepted: 01/09/2020] [Indexed: 10/25/2022]
Abstract
The Canadian Health Measures Survey (CHMS), an ongoing national health survey conducted in two-year cycles, collects extensive biomonitoring data that is used to assess the exposure of Canadians to environmental chemicals of concern. Combining data from multiple cycles of the CHMS allows for the calculation of robust regional estimates of chemical concentrations in blood and urine. The objective of this work was to compare biomarkers of exposure to several environmental chemicals for the provinces of Quebec and Ontario, two major CHMS regions, as well as the entire CHMS (representing Canada) minus Quebec (CMQ), and the entire CHMS minus Ontario (CMO), and to interpret differences between regions. Geometric means and 95th percentiles of blood and/or urinary concentrations of 45 environmental chemicals or their metabolites for Ontario, Quebec, CMQ, and CMO were calculated by combining the two most recent cycles of data available for a chemical (cycles 1 and 2, or cycles 2 and 3) from the first three cycles of the CHMS (2007-2013). Weighted one-way ANOVA was used to test the differences between regional estimates. After applying a Bonferonni-Holm adjustment for multiple comparisons, the following measures were significantly higher in Quebec as compared to Ontario and CMQ: blood lead, urinary lead and the urinary polyaromatic hydrocarbon (PAH) metabolites, 9-hydroxyfluorene, 1-hydroxyphenanthrene, 2- hydroxyphenanthrene and 3-hydroxyphenanthrene. In Quebec compared to CMQ only, urinary 2-hydroxfluorene, 3-hydroxyfluorene, 2-hydroxynaphthalene, and 4-hydroxyphenanthrene were higher. The concentration of urinary fluoride was significantly higher in Ontario as compared to Quebec and CMO. Blood manganese and urinary fluoride were significantly lower in Quebec compared to CMQ, and blood and urinary selenium were significantly lower in Ontario compared to CMO. Regional differences in tobacco use, age of dwellings and drinking water fluoridation are among the possible contributing factors to some of the observed differences. In conclusion, this is the first study where biomonitoring data from multiple cycles of CHMS were combined in order to generate robust estimates for subsets of the Canadian population. Such assessments can contribute to a regional-level prioritization of control measures to reduce the exposure of Canadians to chemicals in their environment.
Collapse
Affiliation(s)
- Mathieu Valcke
- Direction de la Santé Environnementale et de la Toxicologie, Institut National de Santé Publique du Québec, Montréal, Canada; Département de Santé Environnementale et de Santé au Travail, École de Santé Publique de l'Université de Montréal, Canada.
| | | | - Mike Walker
- Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Canada
| | - Michelle Gagné
- Direction de la Santé Environnementale et de la Toxicologie, Institut National de Santé Publique du Québec, Montréal, Canada
| | - Ray Copes
- Public Health Ontario, Toronto, Canada; Dalla Lana School of Public Health, University of Toronto, Canada
| | - Annie St-Amand
- Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, Canada
| |
Collapse
|
9
|
Abstract
Arylamines and nitroarenes are intermediates in the production of pharmaceuticals, dyes, pesticides, and plastics and are important environmental and occupational pollutants. N-Hydroxyarylamines are the toxic common intermediates of arylamines and nitroarenes. N-Hydroxyarylamines and their derivatives can form adducts with hemoglobin (Hb-adducts), albumin, DNA, and tissue proteins in a dose-dependent manner. Most of the arylamine Hb-adducts are labile and undergo hydrolysis in vitro, by mild acid or base, to form the arylamines. According to current knowledge of arylamine adduct-formation, the hydrolyzable fraction is derived from the reaction products of the arylnitroso derivatives that yield arylsulfinamide adducts with cysteine. Hb-adducts are markers for the bioavailability of N-hydroxyarylamines. Hb-adducts of arylamines and nitroarenes have been used for many biomonitoring studies for over 30 years. Hb-adducts reflect the exposure history of the last four months. Biomonitoring of urinary metabolites is a less invasive process than biomonitoring blood protein adducts, and urinary metabolites have served as short-lived biomarkers of exposure to these hazardous chemicals. However, in case of intermittent exposure, urinary metabolites may not be detected, and subjects may be misclassified as nonexposed. Arylamines and nitroarenes and/or their metabolites have been measured in urine, especially to monitor the exposure of workers. This review summarizes the results of human biomonitoring studies involving urinary metabolites and Hb-adducts of arylamines and nitroarenes. In addition, studies about the relationship between Hb-adducts and diseases are summarized.
Collapse
Affiliation(s)
- Gabriele Sabbioni
- Institute of Environmental and Occupational Toxicology , Casella Postale 108, CH-6780 Airolo, Switzerland.,Alpine Institute of Chemistry and Toxicology , CH-6718 Olivone, Switzerland.,Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität , D-80336 München, Germany
| |
Collapse
|
10
|
Killilea DW, Chow D, Xiao SQ, Li C, Stoller ML. Flame retardant tris(1,3-dichloro-2-propyl)phosphate (TDCPP) toxicity is attenuated by N-acetylcysteine in human kidney cells. Toxicol Rep 2017; 4:260-264. [PMID: 28959647 PMCID: PMC5615114 DOI: 10.1016/j.toxrep.2017.05.003] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2017] [Revised: 05/11/2017] [Accepted: 05/14/2017] [Indexed: 12/21/2022] Open
Abstract
Prolonged exposure to the flame retardants found in many household products and building materials is associated with adverse developmental, reproductive, and carcinogenic consequences. While these compounds have been studied in numerous epidemiological and animal models, less is known about the effects of flame retardant exposure on cell function. This study evaluated the toxicity of the commonly used fire retardant tris(1,3-dichloro-2-propyl)phosphate (TDCPP) in cell line derived from the kidney, a major tissue target of organohalogen toxicity. TDCPP inhibited cell growth at lower concentrations (IC50 27 μM), while cell viability and toxicity were affected at higher concentrations (IC50 171 μM and 168 μM, respectively). TDCPP inhibited protein synthesis and caused cell cycle arrest, but only at higher concentrations. Additionally, the antioxidant N-acetylcysteine (NAC) reduced cell toxicity in cells treated with TDCPP, suggesting that exposure to TDCPP increased oxidative stress in the cells. In summary, these data show that low concentrations of TDCPP result in cytostasis in a kidney cell line, whereas higher concentrations induce cell toxicity. Furthermore, TDCPP toxicity can be attenuated by NAC, suggesting that antioxidants may be effective countermeasures to some organohalogen exposures.
Collapse
Key Words
- ATSDR, Agency for Toxic Substances and Disease Registry
- DMEM, Dulbecco’s Modified Eagle Medium
- DMSO, dimethyl sulfoxide
- EDTA, ethylenediamine tetraacetic acid
- FBS, fetal bovine serum
- N-acetylcysteine (PubChem CID: 12035)
- NAC, N-acetylcysteine
- SFFCPF, San Francisco Firefighters Cancer Prevention Foundation
- TDCPP, tris(1,3-dichloro-2-propyl)phosphate
- TR, thyroid hormone receptor
- Tris(1,3-dichloro-2-propyl)phosphate (PubChem CID: 26177)
- Tris, tris(2,3-dibromopropyl)phosphate
- antioxidant
- cell cycle
- cell toxicity
- cytostasis
- flame retardant
Collapse
Affiliation(s)
- David W. Killilea
- Children’s Hospital Oakland Research Institute, Oakland, CA, USA
- Department of Urology, University of California, San Francisco, CA, USA
- Corresponding author at: Children’s Hospital Oakland Research Institute, 5700 Martin Luther King, Jr. Way, Oakland, California 94609, USA.Children’s Hospital Oakland Research InstituteOaklandCAUSA
| | - Darryl Chow
- Children’s Hospital Oakland Research Institute, Oakland, CA, USA
| | - Sheng Qi Xiao
- Children’s Hospital Oakland Research Institute, Oakland, CA, USA
| | - Charles Li
- Children’s Hospital Oakland Research Institute, Oakland, CA, USA
| | | |
Collapse
|